Aprepitant against pruritus in patients with solid tumours.
Vincenzi
Bruno
B
Medical Oncology, University Campus Bio-Medico, Rome, 00128 Rome, Italy. b.vincenzi@unicampus.it
Fratto
Maria Elisabetta
ME
Santini
Daniele
D
Tonini
Giuseppe
G
D000932:Antiemetics / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000077608:Aprepitant; D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D011537:Pruritus / Q000139:chemically induced / Q000188:drug therapy*; D018040:Receptors, Neurokinin-1 / Q000187:drug effects
D000932:Antiemetics; D009025:Morpholines; D018040:Receptors, Neurokinin-1; D000077608:Aprepitant